Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Emergency-room heparinization before primary PCI in acute ST-segment elevation myocardial infarction
ChiCTR1800016386Phase 4Recruiting
- Sponsor
- Tianjin Fifth Central Hospital
- Start
- Nov 2015
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of heparin in myocardial infarction (MI) (2 arms), sponsored by Tianjin Fifth Central Hospital. Primary endpoints: Coronary angiography TIMI flow grade and Door-to-balloon time. Started Nov 2015; status: recruiting.
02
Drugs
heparin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on ChiCTR1800016386.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800016386.